Posterior Reversibl Ensefalopati Sendromu: Sistemik Lupus Eritematozuslu hastalarda görülen nadir ve acil klinik bir antite
Öz
Özet
PRES hipertansiyon, başağrısı, konfüzyon, nöbet, görme değişiklikleri ile karakterize posterior serebral dolaşımda (beyin sapı, serebellum, parietal lob, temporal lob, oksipital lob ve posterior ön lob dahil olabilen) vazojenik ödem şeklinde görülen klinik ve radyolojik bir antitedir. PRES sendromlu hastaların yaklaşık yarısında sistemik lupus eritematozus (SLE) gibi otoimmün bir hastalık öyküsü vardır. PRES sendromu gelişen SLE hastalarında erken tanı ve tedavi önemlidir. Bu sayede çoğunlukla benign gidişatlı bir hastalık erkenden tanınmış olur ve gereksiz tetkiklerin önüne geçilebilir.
Abstract:
PRES is a
clinical and radiological entity in the form of vasogenic edema in the
posterior cerebral circulation (including brain stem, cerebellum, parietal
lobe, temporal lobe, occipital lobe and posterior anterior lobe) characterized
by hypertension, headache, confusion, seizures, visual changes. Approximately
half of patients with PRES syndrome have a history of autoimmune disease such
as systemic lupus erythematosus (SLE). Early diagnosis and treatment are
important in SLE patients with PRES syndrome. In this way, usually a benign
disease is recognized early and unnecessary examinations can be prevented.
Anahtar Kelimeler
Posterior Reversibl Ensefalopati Sendromu,Sistemik Lupus Eritematozus
Kaynakça
- 1. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 1996; 334:494.
- 2. Cui HW, Lei RY, Zhang SG, et al. Clinical features, outcomes and risk factors for posterior reversible encephalopathy syndrome in systemic lupus erythematosus: a case-control study. Lupus 2019; 28, 961–969.
- 3. Damrongpipatkul U, Oranratanachai K, Kasitanon N and et al. Clinical features, outcome, and associated factors for posterior reversible encephalopathy in Thai patients with systemic lupus erythematosus: a case-control study. 2018; 37: 691–702.
- 4. Pande A, Kumiko A, Ishikura R, et al. Clinicoradiological Factors Influencing the Reversibility of Posterior Reversibl Encephalopathy Syndrome: A Multicenter Study. Radiation Medicine 2006; 24: 659–668.
- 5. Dong XY, Bai CB, Nao JF. Clinical and radiological features of posterior reversible encephalopathy syndrome in patients with preeclampsia and eclampsia. Clin Radiol 2017; 72: 887–895.
- 6. Jung SM, Moon SJ, Kwok SK, et al. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: Risk factors and clinical outcome. Lupus 2013; 22: 885–891.
- 7. Bertsias GK, Ioannidis JP, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010; 69:2074-82.
- 8. Hanly JG, McCurdy G, Fougere L , et al. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol. 2004; 31:2156-2162.
- 9. Dardis C, Craciun R, Schell R. Posterior reversible encephalopathy syndrome in the setting of COPD: Proposed pathogenesis. Med Hypotheses 2013; 80: 197–200.
- 10. Lee SC, Dickson DW, Liu W, et al. Induction of nitric oxidesynthase activity in human astrocytes by interleukin-1 beta and interferon-gamma. J Neuroimmunol 1993; 46: 19–24.